Different conformations of amyloid β induce neurotoxicity by distinct mechanisms in human cortical neurons

Journal of Neuroscience

Volumn 26, Issue 22, 2006, Pages 6011-6018

  Deshpande, Atul ^a   Mina, Erene ^b   Glabe, Charles ^b   Busciglio, Jorge ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease; Amyloid ; Apoptosis; Mitochondria; Oligomers; Synapses

Indexed keywords

AMYLOID BETA PROTEIN; OLIGOMER; NEUROTOXIN;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN CELL; CALCIUM TRANSPORT; CELL DEATH; CONTROLLED STUDY; DYSTROPHY; FETUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MITOCHONDRION; NEUROTOXICITY; PRIORITY JOURNAL; PROTEIN LOCALIZATION; BRAIN CORTEX; CELL CULTURE; CHEMISTRY; CYTOLOGY; DRUG EFFECT; NERVE CELL; PATHOLOGY; PHYSIOLOGY; PRENATAL DEVELOPMENT; PROTEIN CONFORMATION; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOPTOSIS; CELLS, CULTURED; CEREBRAL CORTEX; HUMANS; NEURONS; NEUROTOXINS; PROTEIN CONFORMATION; SYNAPSES;

EID: 33745268224     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.1189-06.2006     Document Type: Article

References (75)

1. Arispe N (2004) Architecture of the Alzheimer's AβP ion channel pore. J Membr Biol 197:33-48.
2. 1-42. J Neurochem 75:1219-1233.
3. Berridge MJ, Bootman MD, Lipp P (1998) Calcium - a life and death signal. Nature 395:645-648.
4. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416:507-511.
5. Busciglio J, Lorenzo A, Yankner BA (1992) Methodological variables in the assessment of beta amyloid neurotoxicity. Neurobiol Aging 13:609-612.
6. Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888.
7. Busciglio J, Pelsman A, Wong C, Pigino G, Yuan M, Mori H, Yankner BA (2002) Altered metabolism of the amyloid β precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33:677-688.
8. Bush AI, Pettingell Jr WH, Paradis MD, Tanzi RE (1994) Modulation of Aβ adhesiveness and secretase site cleavage by zinc. J Biol Chem 269:12152-12158.
9. Cai J, Yang J, Jones DP (1998) Mitochondrial control of apoptosis: the role of cytochrome c. Biochim Biophys Acta 1366:139-149.
10. Caughey B, Lansbury PT (2003) Protofibrils, pores, fibrils, and neurodegeneration: separating the responsible protein aggregates from the innocent bystanders. Annu Rev Neurosci 26:267-298.
11. Cherny RA, Atwood CS, Xilinas ME, Gray DN, Jones WD, McLean CA, Barnham KJ, Volitakis I, Fraser FW, Kim Y, Huang X, Goldstein LE, Moir RD, Lim JT, Beyreuther K, Zheng H, Tanzi RE, Masters CL, Bush AI (2001) Treatment with a copper-zinc chelator markedly and rapidly inhibits β-amyloid accumulation in Alzheimer's disease transgenic mice. Neuron 30:665-676.
12. 1-42 into globular neurotoxins. Biochemistry 42:12749-12760.
13. Dahlgren KN, Manelli AM, Stine Jr WB, Baker LK, Krafft GA, LaDu MJ (2002) Oligomeric and fibrillar species of amyloid-β peptides differentially affect neuronal viability. J Biol Chem 277:32046-32053.
14. Danial NN, Korsmeyer SJ (2004) Cell death: critical control points. Cell 116:205-219.
15. Demuro A, Mina E, Kayed R, Milton SC, Parker I, Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280:17294-17300.
16. 2+ in cell physiology and pathophysiology. Cell Calcium 28:339-348.
17. Earnshaw WC, Martins LM, Kaufmann SH (1999) Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68:383-424.
18. Fan TJ, Han LH, Cong RS, Liang J (2005) Caspase family proteases and apoptosis. Acta Biochim Biophys Sin (Shanghai) 37:719-727.
19. Frederickson CJ, Bush AI (2001) Synaptically released zinc: physiological functions and pathological effects. Biometals 14:353-366.
20. Georganopoulou DG, Chang L, Nam JM, Thaxton CS, Mufson EJ, Klein WL, Mirkin CA (2005) Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proc Natl Acad Sci USA 102:2273-2276.
21. Geula C, Wu CK, Saroff D, Lorenzo A, Yuan M, Yankner BA (1998) Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat Med 4:827-831.
22. Glabe CG (2004) Conformation-dependent antibodies target diseases of protein misfolding. Trends Biochem Sci 29:542-547.
23. Gong Y, Chang L, Viola KL, Lacor PN, Lambert MP, Finch CE, Krafft GA, Klein WL (2003) Alzheimer's disease-affected brain: presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc Natl Acad Sci USA 100:10417-10422.
24. Grace EA, Busciglio J (2003) Aberrant activation of focal adhesion proteins mediates fibrillar amyloid β-induced neuronal dystrophy. J Neurosci 23:493-502.
25. Grace EA, Rabiner CA, Busciglio J (2002) Characterization of neuronal dystrophy induced by fibrillar amyloid β: implications for Alzheimer's disease. Neuroscience 114:265-273.
26. Gylys KH, Fein JA, Yang F, Wiley DJ, Miller CA, Cole GM (2004) Synaptic changes in Alzheimer's disease: increased amyloid-β and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence. Am J Pathol 165:1809-1817.
27. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356.
28. Hartley DM, Walsh DM, Ye CP, Diehl T, Vasquez S, Vassilev PM, Teplow DB, Selkoe DJ (1999) Protofibrillar intermediates of amyloid β-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci 19:8876-8884.
29. Helguera P, Pelsman A, Pigino G, Wolvetang E, Head E, Busciglio J (2005) ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons. J Neurosci 25:2295-2303.
30. Johnstone RW, Ruefli AA, Lowe SW (2002) Apoptosis: a link between cancer genetics and chemotherapy. Cell 108:153-164.
31. Joza N, Susin SA, Daugas E, Stanford WL, Cho SK, Li CY, Sasaki T, Elia AJ, Cheng HY, Ravagnan L, Ferri KF, Zamzami N, Wakeham A, Hakem R, Yoshida H, Kong YY, Mak TW, Zuniga-Pflucker JC, Kroemer G, Penninger JM (2001) Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death. Nature 410:549-554.
32. Kagan BL, Hirakura Y, Azimov R, Azimova R, Lin MC (2002) The channel hypothesis of Alzheimer's disease: current status. Peptides 23:1311-1315.
33. Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, Cotman CW, Glabe CG (2003) Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science 300:486-489.
34. Kayed R, Sokolov Y, Edmonds B, McIntire TM, Milton SC, Hall JE, Glabe CG (2004) Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases. J Biol Chem 279:46363-46366.
35. Kerkovich DM, Sapp D, Weidenheim K, Brosnan CF, Pfeiffer SE, Yeh HH, Busciglio J (1999) Fetal human cortical neurons grown in culture: morphological differentiation, biochemical correlates, and development of electrical activity. Int J Dev Neurosci 17:347-356.
36. Klein WL (2002) Aβ toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem Int 41:345-352.
37. Korge P, Honda HM, Weiss JN (2002) Protection of cardiac mitochondria by diazoxide and protein kinase C: implications for ischemic preconditioning. Proc Natl Acad Sci USA 99:3312-3317.
38. N-40, N-42 oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077-4081.
39. Lacor PN, Buniel MC, Chang L, Fernandez SJ, Gong Y, Viola KL, Lambert MP, Velasco PT, Bigio EH, Finch CE, Krafft GA, Klein WL (2004) Synaptic targeting by Alzheimer's-related amyloid β oligomers. J Neurosci 24:10191-10200.
40. Lacor PN, Sanz-Clemente A, Viola KL, Klein WL (2005) Changes in NMDA receptor subunit 1 and 2B expression in ADDL-treated hippocampal neurons. Soc Neurosci Abstr 31:786.17.
41. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signaling in Alzheimer's disease. Nat Rev Neurosci 3:862-872.
42. 1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci USA 95:6448-6453.
43. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, Walz T, Lansbury Jr PT (2002a) α-Synuclein, especially the Parkinson's disease-associated mutants, forms pore-like annular and tubular protofibrils. J Mol Biol 322:1089-1102.
44. Lashuel HA, Hartley DM, Balakhaneh D, Aggarwal A, Teichberg S, Callaway DJ (2002b) New class of inhibitors of amyloid-β fibril formation. Implications for the mechanism of pathogenesis in Alzheimer's disease. J Biol Chem 277:42881-42890.
45. Lesné S, Koh MT, Kotilinek L, Kayed R, Glabe CG, Yang A, Gallagher M, Ashe KH (2006) A specific amyloid-β protein assembly in the brain impairs memory. Nature 440:352-357.
46. Li YP, Bushnell AF, Lee CM, Perlmutter LS, Wong SK (1996) β-Amyloid induces apoptosis in human-derived neurotypic SH-SY5Y cells. Brain Res 738:196-204.
47. Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119:873-887.
48. Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J (1999) Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease. Am J Pathol 155:853-862.
49. Mathie A, Sutton GL, Clarke CE, Veale EL (2006) Zinc and copper: pharmacological probes and endogenous modulators of neuronal excitability. Pharmacol Ther, in press.
50. Mattson MP (1992) Calcium as sculptor and destroyer of neural circuitry. Exp Gerontol 27:29-49.
51. Mattson MP, Rydel RE (1992) β-Amyloid precursor protein and Alzheimer's disease: the peptide plot thickens. Neurobiol Aging 13:617-621.
52. 2+ exchanger and AKT. J Biol Chem 280:38505-38512.
53. Mocchegiani E, Bertoni-Freddari C, Marcellini F, Malavolta M (2005) Brain, aging, and neurodegeneration: role of zinc ion availability. Prog Neurobiol 75:367-390.
54. Naslund J, Haroutunian V, Mohs R, Davis KL, Davies P, Greengard P, Buxbaum JD (2000) Correlation between elevated levels of amyloid β-peptide in the brain and cognitive decline. JAMA 283:1571-1577.
55. Nguyen HD, Hall CK (2004) Molecular dynamics simulations of spontaneous fibril formation by random-coil peptides. Proc Natl Acad Sci USA 101:16180-16185.
56. Oddo S, Caccamo A, Tran L, Lambert MP, Glabe CG, Klein WL, LaFerla FM (2006) Temporal profile of amyloid-beta (Aβ) oligomerization in an in vivo model of Alzheimer disease. A link between Aβ and tau pathology. J Biol Chem 281:1599-1604.
57. Pelsman A, Hoyo-Vadillo C, Gudasheva TA, Seredenin SB, Ostrovskaya RU, Busciglio J (2003) GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. Int J Dev Neurosci 21:117-124.
58. 1-42 production triggered by sustained increase of cytosolic calcium concentration induces neuronal death. J Neurochem 88:1140-1150.
59. Pike CJ, Cummings BJ, Cotman CW (1992) β-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology. NeuroReport 3:769-772.
60. Polster BM, Fiskum G (2004) Mitochondrial mechanisms of neural cell apoptosis. J Neurochem 90:1281-1289.
61. Quist A, Doudevski I, Lin H, Azimova R, Ng D, Frangione B, Kagan B, Ghiso J, Lal R (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci USA 102:10427-10432.
62. Sanchez I, Mahlke C, Yuan J (2003) Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders. Nature 421:373-379.
63. 2+: a control point for apoptosis. Science 300:135-139.
64. Slee EA, Adrain C, Martin SJ (1999) Serial killers: ordering caspase activation events in apoptosis. Cell Death Differ 6:1067-1074.
65. Spires TL, Meyer-Luehmann M, Stern EA, McLean PJ, Skoch J, Nguyen PT, Bacskai BJ, Hyman BT (2005) Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J Neurosci 25:7278-7287.
66. Stern EA, Bacskai BJ, Hickey GA, Attenello FJ, Lombardo JA, Hyman BT (2004) Cortical synaptic integration in vivo is disrupted by amyloid-β plaques. J Neurosci 24:4535-4540.
67. Takahashi RH, Almeida CG, Kearney PF, Yu F, Lin MT, Milner TA, Gouras GK (2004) Oligomerization of Alzheimer's β-amyloid within processes and synapses of cultured neurons and brain. J Neurosci 24:3592-3599.
68. Tanzi RE (2005) The synaptic Aβ hypothesis of Alzheimer disease. Nat Neurosci 8:977-979.
69. Thundimadathil J, Roeske RW, Jiang HY, Guo L (2005) Aggregation and porin-like channel activity of a beta sheet peptide. Biochemistry 44:10259-10270.
70. Tsai J, Grutzendler J, Duff K, Gan WB (2004) Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nat Neurosci 7:1181-1183.
71. van Loo G, Saelens X, van Gurp M, MacFarlane M, Martin SJ, Vandenabeele P (2002) The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ 9:1031-1042.
72. Walker NI, Harmon BV, Gobe GC, Kerr JF (1988) Patterns of cell death. Methods Achiev Exp Pathol 13:18-54.
73. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002a) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535-539.
74. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ (2002b) Amyloid-β oligomers: their production, toxicity, and therapeutic inhibition. Biochem Soc Trans 30:552-557.
75. 1-42 inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133-140.